FIELD: medicine.
SUBSTANCE: electrical bowel action is measured. If observing a decrease of a slow wave frequency of the small intestine electromyogram from 23-27 to 16.5-19 a minute and an amplitude from 0.24-0.3 mV to 0.18-0.22 mV, a decrease of a slow wave frequency from 17-25 to 7.2-8.4 a minute and an amplitude from 0.22-0.28 mV to 0.12-0.16 mV of the ascending large intestine electromyogram, a decrease of a slow wave frequency from 12-14.5 to 5.3-6.3 a minute and a decrease of an amplitude from 0.16-0.20 mV to 0.11-0.14 mV of the sigmoid electromyogram, the treatment is considered to be effective.
EFFECT: assessment accuracy with reducing side effects of the examination.
4 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DIAGNOSING THE SEVERITY OF IRRITABLE BOWEL SYNDROME | 2017 |
|
RU2668496C2 |
DIAGNOSTIC METHOD OF DISACCHARIDASE DEFICIENCY IN ADULT PATIENTS | 2017 |
|
RU2655205C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR HEPATIC STEATOSIS AND STEATOHEPATITIS | 2013 |
|
RU2545990C2 |
METHOD OF LACTASE DEFICIENCY IN ADULTS TREATMENT | 2017 |
|
RU2684099C1 |
METHOD FOR ASSESSING EFFICACY OF NUTRITIONAL SUPPORT ACCOMPANYING ULCERATIVE COLITIS | 2013 |
|
RU2552319C1 |
METHOD FOR IBS-SIMILAR SYNDROME DIAGNOSTICS WITH ULCERATIVE COLITIS | 2016 |
|
RU2649468C2 |
METHOD FOR DIAGNOSING SEVERE PSEUDOMEMBRANOUS COLITIS IN PATIENTS AFTER CORONAVIRUS INFECTION | 2022 |
|
RU2786752C1 |
METHOD OF TREATING CHRONIC CONSTIPATION AND FUNCTIONAL ANOREXIA | 2013 |
|
RU2545988C1 |
DIAGNOSTIC TECHNIQUE FOR ASYMPTOMATIC CELIAC DISEASE IN ADULTS | 2020 |
|
RU2747523C1 |
METHOD FOR DETERMINING RISK OF ISCHEMIC HEART DISEASE | 2013 |
|
RU2532361C1 |
Authors
Dates
2015-12-10—Published
2014-11-21—Filed